Sanofi Share Price Today: Live Updates & Key Insights
Sanofi share price today is $44.37, up -1.63%. The stock opened at $45.28 against the previous close of $45.34, with an intraday high of $45.45 and low of $44.365.
Sanofi Share Price Chart
Sanofi Share Price Performance
Sanofi Institutional Holdings
Sanofi Market Status
Sanofi Fundamentals
Market Cap 108619.27 M
PB Ratio 1.3117
PE Ratio 19.3074
Enterprise Value 121375.60 M
Total Assets 126806.00 M
Volume 4788431
Sanofi Company Financials
About Sanofi & investment objective
Company Information Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. Sanofi has a strategic collaboration with miRecule, Inc. to facilitate the advancement of therapy DUX4, a genetic driver of debilitating muscular disease. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Organisation Drug Manufacturers - General
Employees 74846
Industry Drug Manufacturers - General
CEO Mr. Olivier Charmeil
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Sanofi FAQs
What is the share price of Sanofi today?
The current share price of Sanofi is $44.37.
Can I buy Sanofi shares in India?
Yes, Indian investors can buy Sanofi shares by opening an international trading and demat account with Motilal Oswal.
How to buy Sanofi shares in India?
You can easily invest in Sanofi shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Sanofi shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Sanofi.
Can I buy fractional shares of Sanofi?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Sanofi?
Sanofi has a market cap of $108619.27 M.
In which sector does Sanofi belong?
Sanofi operates in the Drug Manufacturers - General sector.
What documents are required to invest in Sanofi stocks?
To invest, you typically need:
What is the PE and PB ratio of Sanofi?
The PE ratio of Sanofi is 19.31 and the PB ratio is 1.31.